☰

Jeffrey Chamberlain, PhD

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
muscle gene therapy, DMD
Google:
"Jeffrey Chamberlain"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Stephen D. Hauschka grad student University of Washington (Cell Biology Tree)
C. Thomas Caskey post-doc Baylor College of Medicine (Neurotree)

Children

Sign in to add trainee
Gregory E Crawford grad student (Computational Biology Tree)
Daniel E. Michele grad student 2000 University of Michigan
Christiana DelloRusso grad student 2002 University of Michigan
Scott Q. Harper grad student 1997-2002 University of Michigan
Dennis J. Hartigan-O'Connor grad student 2003 University of Michigan
Michael J. Blankinship grad student 2005 University of Michigan
Luke M. Judge grad student 2006 University of Washington
Brian R. Schultz grad student 2009 University of Washington
Andrea L. Arnett grad student 2011 University of Washington
Lindsey A. Muir grad student 2012 University of Washington

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lorena MDSV, Santos EK, Ferretti R, et al. (2023) Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Research Square
Benasutti H, Maricelli JW, Seto J, et al. (2023) Efficacy and muscle safety assessment of fukutin-related protein gene therapy. Molecular Therapy. Methods & Clinical Development. 30: 65-80
Hindi SM, Petrany MJ, Greenfeld E, et al. (2023) Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell
Cikes D, Elsayad K, Sezgin E, et al. (2023) Author Correction: PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing. Nature Metabolism
Hindi SM, Petrany MJ, Greenfeld E, et al. (2023) Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Biorxiv : the Preprint Server For Biology
Cikes D, Elsayad K, Sezgin E, et al. (2023) PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing. Nature Metabolism
Piepho AB, Lowe J, Cumby LR, et al. (2023) Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model. Molecular Therapy. Methods & Clinical Development. 28: 344-354
Chamberlain J, Robb M, Braun S, et al. (2023) Micro-dystrophin expression as a surrogate endpoint for Duchenne muscular dystrophy clinical trials. Human Gene Therapy
Birch SM, Lawlor MW, Conlon TJ, et al. (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815
Boehler JF, Brown KJ, Beatka M, et al. (2022) Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscular Disorders : Nmd
See more...